Arincare Completes Series B+ Funding Round to Accelerate Thailand's Healthcare Ecosystem Transformation

Strategic investment from Taiwan and Thailand strengthens Arincare’s position as Thailand’s leading pharmacy ecosystem platform and marks a significant milestone for the country’s HealthTech ecosystem

Arincare, Thailand’s leading pharmacy management and healthcare ecosystem platform, today announced the successful completion of its Series B+ funding round led by Taiwania Hive Ventures, with participation from follow-on investors from Taiwan including Cathay Ventures and MyTrex Health Technologies, alongside Thailand-based investors InnoSpace Thailand and SSN.

The new funding marks an important milestone in Arincare’s growth journey and reflects growing international confidence in Thailand’s innovation ecosystem and healthcare technology sector.

Founded with the vision of empowering pharmacies through technology and data, Arincare has grown into Thailand’s largest pharmacy management and ecosystem platform, serving more than 6,000 registered pharmacies and supporting over 12,000 pharmacists nationwide on a daily basis.

Over the past decade, Arincare has also established itself as one of the most trusted brands within Thailand’s pharmaceutical industry, helping bridge pharmaceutical manufacturers, distributors, leading healthcare brands, and pharmacies nationwide through an integrated technology and healthcare ecosystem.

Proceeds from the funding round will be used to strengthen the company’s technology platform, expand ecosystem capabilities, enhance AI and analytics infrastructure, improve operational scalability, and accelerate strategic partnerships across the healthcare value chain.

Over the past decade, Arincare has become more than a technology platform. We have become part of the operational backbone supporting thousands of pharmacies and pharmacists across Thailand every day. Building trust in healthcare takes time, and we are proud to have earned credibility across the industry through reliable execution, strong partnerships, and standards that can scale sustainably

Teera Kanokkanjanarat, Co-Founder and Chief Executive Officer of Arincare said

We see enormous opportunities ahead. As healthcare continues to evolve, we believe technology, data, and ecosystem collaboration will reshape how healthcare is delivered and accessed. We are excited to work closely with partners who share the ambition of creating meaningful impact and growing together. 

The participation of strategic investors from Taiwan is expected to create opportunities for cross-border collaboration across healthcare technology, pharmaceutical innovation, healthcare services, and regional ecosystem development. Taiwan’s healthcare ecosystem has long been recognized for its strengths in medical technology, pharmaceutical innovation, and healthcare infrastructure, creating strong strategic alignment with Arincare’s long-term vision.

This investment also represents an important milestone for Thailand’s startup ecosystem. Beyond supporting Arincare’s next phase of growth, the transaction reflects increasing international confidence in Thai founders, local innovation, and the country’s long-term healthcare opportunities. The participation of international investors through this round also represents meaningful foreign direct investment into a Thailand-based technology company, reinforcing Thailand’s growing role within the regional innovation landscape.

Together with support received across previous funding rounds from leading strategic organizations including Chularat Hospital Group (CHG), Max Ventures , and Nexter Ventures, the venture capital arm of SCG, Arincare continues to strengthen its position as one of Thailand’s leading HealthTech companies and a trusted long-term platform within Thailand’s healthcare ecosystem.

As Arincare enters its next phase of growth, the company remains focused on strengthening technology capabilities, expanding healthcare accessibility, and creating sustainable long-term value across the healthcare ecosystem.

Hsin-fu Huang, Managing partner at Taiwania Hive Ventures said 

The investment in Arincare perfectly echoes our investment theory for the Southeast Asia region. We see immense potential in applying data and AI technology to traditional industries like the pharmacy business - a market that remains largely underserved and ripe for accelerated growth. What makes this investment particularly exciting is the strategic alignment with our partners from Taiwan. This partnership and the resulting synergy will be instrumental in supporting Arincare’s next phase of expansion. 

InnoSpace Thailand is proud to support Arincare as a leading Thai HealthTech company driving digital transformation for community pharmacies. Pharmacies are one of the most accessible healthcare touchpoints for people across Thailand, and Arincare’s platform can help improve efficiency, connectivity, and healthcare access at scale.

Narusan Dhanvarjor, Chief Executive Office & Head of Investment of InnoSpace Thailand said

This investment reflects our commitment to supporting Thai startups with strong technology, real industry impact, and the potential to connect Thailand’s innovation ecosystem with international partners.”